SCHEMBL8955799

SCHEMBL8955799

C=CCc1ccc(C(C)(C)C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TSHR P16473 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
TP53 P04637 2/20 0.52
CYP3A4 P08684 2/20 0.52
ALOX15 P16050 1/20 0.52
ALOX12 P18054 1/20 0.52
PPARG P37231 2/20 0.42
PPARD Q03181 2/20 0.42
PPARA Q07869 1/20 0.42
XDH P47989 1/20 0.42
KCNH2 Q12809 1/20 0.41
LMNA P02545 2/20 0.41
TYR P14679 1/20 0.41
BCHE P06276 4/20 0.41
ACHE P22303 4/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH2 P05091 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6324230 0.94 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL1428666 0.83 ALDH1A1 (0.48) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL17012466 0.83 ALDH1A1 (0.48) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL13961178 0.83 ALDH1A1 (0.48) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
Hydrochloric Acid SCHEMBL28890760 0.81 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL173301 0.80 ALDH1A1 (0.64) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL10524361 0.79 ALDH1A1 (0.46) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL3639494 0.79 TSHR (0.57) TSHRTP53KCNH2LMNATYR
SCHEMBL3073220 0.79 TSHR (0.47) TSHRTP53KCNH2LMNATYR
SCHEMBL9262525 0.78 TSHR (0.43) TSHRTP53KCNH2LMNATYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60152429-A None JP disclosed
US-9309188-B2 Method for allylating and vinylating aryl, heteroaryl, alkyl, and alkene halogenides using transition metal catalysis Saitigo GmbH (DE) 2016-04-12 US disclosed
US-20130184485-A1 Method for Allylating and Vinylating Aryl, Heteroaryl, Alkyl, and Alkene Halogenides Using Transition Metal Catalysis SALTIGO GMBH (DE) 2013-07-18 US disclosed
US-5486533-A DIAZOLE OR TRIAZOLES WITH SILFIDES UNIROYAL CHEMICAL COMPANY, INC. (US) 1996-01-23 US disclosed
EP-0663904-A1 FUNGICIDAL SUBSTITUTED AZOLE DERIVATIVES UNIROYAL CHEMICAL COMPANY, Inc. (US) 1995-07-26 EP disclosed
WO-1994008978-A1 FUNGICIDAL SUBSTITUTED AZOLE DERIVATIVES UNIROYAL CHEMICAL COMPANY, INC. (US) 1994-04-28 WO disclosed
EP-0259977-A2 Tertiary amine compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-03-16 EP disclosed
EP-0074273-B1 HYDROCARBON RESIN AND MODIFIED HYDROCARBON RESIN PRODUCT THEREOF MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1986-11-05 EP disclosed
JP-S60152429-A PRODUCTION OF 2,6-DIHALOALKYLBENZENE OR 2,6- DIHALOALKENYLBENZENE HARADA SUKETAKA 1985-08-10 JP disclosed
US-4533700-A MODIFIED WITH AN UNSATURATED ACID OR HYDROGEN, USEFUL IN ADHESIVES AND TRAFFIC PAINTS MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1985-08-06 US disclosed
US-4513130-A A COPOLYMER CONTAINIONG 9,10-DIHYDRODICYCLOPENTADIENE AND OR ITS PERIVATIVES MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1985-04-23 US disclosed
US-4482755-A High yield process for preparing 4,4'-biphenol and para-alkylbenzenes ICI AMERICAS INC. (US) 1984-11-13 US disclosed
EP-0074273-A1 Hydrocarbon resin and modified hydrocarbon resin product thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1983-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184485-A1 Method for Allylating and Vinylating Aryl, Heteroaryl, Alkyl, and Alkene Halogenides Using Transition Metal Catalysis VRK2, VRK1, GRK1 ALDH1A1 2413/4885TSHR 446/4885SMN1; SMN2 3892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.